Francesca Palandri

70PUBLICATIONS
195CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Molecular targetsPredictive and prognostic markersMedical mycologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Jul 15, 2026
Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY-1 and MOMENTUM Trials.

|Jun 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis.

|Jun 11, 2026
A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with Ruxolitinib.

|May 12, 2026
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

|May 05, 2026
MDM2 inhibitors in myeloid cancers: from basic biology to clinical use in myeloproliferative neoplasms.

|Apr 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

Pageof 12

Frequent Collaborators

28 joint publications

Massimo Breccia

26 joint publications

Alessandra Iurlo

20 joint publications

Mario Tiribelli

20 joint publications

Valerio De Stefano